REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/28/2025
Back to search
Official data from USPTO
DOGMA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DOGMA THERAPEUTICS
ST13
US500000088741381Class
42
Filing
88741381
Registration
6112431
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
07/29/2025
Trademark type
Word
Nice classes
42
Filing date
12/29/2019
Registration date
07/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2020
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/25/2015
First use in commerce
09/25/2015
Drawing code
4
Owner type
03
Owner location
Boxford, MA
Examiner
GARTNER, JOHN
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Dogma Therapeutics, Inc.
Representatives
MATTHEW SAUNDERS SAUNDERS & SILVERSTEIN LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; Pharmaceutical research and development; Pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2020
PUBO
PUBLISHED FOR OPPOSITION
05/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/22/2020
ALIE
ASSIGNED TO LIE
04/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/25/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/25/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/25/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/25/2020
DOCK
ASSIGNED TO EXAMINER
03/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2020
NWAP
NEW APPLICATION ENTERED
01/01/2020
Continuous trademark protection
Get notified about every new filing that threatens DOGMA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.